高级检索
当前位置: 首页 > 详情页

Simultaneous determination of plasma nicotine and cotinine by UHPLC-MS/MS in C57BL/6 mice and its application in a pharmacokinetic study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Sch Stomatol, Lab Tissue Regenerat & Immunol, 4 Tiantanxili, Beijing 100050, Peoples R China [2]Capital Med Univ, Sch Stomatol, Dept Periodont, Beijing Key Lab Tooth Regenerat & Funct Reconstru, 4 Tiantanxili, Beijing 100050, Peoples R China [3]Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, 119 Nansihuan West Rd, Beijing 100070, Peoples R China [4]Capital Med Univ, Coll Pharmaceut Sci, Dept Clin Pharmacol, Beijing, Peoples R China [5]Capital Med Univ, Beijing Tongren Hosp, Dept Pharm, Beijing, Peoples R China
出处:
ISSN:

关键词: cotinine method development and validation nicotine pharmacokinetics UHPLC-MS MS

摘要:
Plasma concentrations of nicotine and its active metabolite cotinine are highly correlated with its biological effects. A UHPLC-MS/MS method was developed, validated and applied for nicotine and cotinine analysis in mice plasma. Chromatographic separation was achieved on a BEH HILIC column using acetonitrile (0.1% formic acid) and 10 mm ammonium formate as mobile phase. The gradient elution was performed at 0.4 mL/min with a run time of 3.6 min. The quantitative ion transition was m/z 163.1 > 130.0 for nicotine, m/z 177.1 > 80.0 for cotinine and m/z 167.1 > 134.0 for nicotine-D-4 (internal standard, IS). For both nicotine and cotinine, the calibration range was 5-500 ng/mL with 5 ng/mL as the lower limit of quantitation, and the intra- and inter-day bias and imprecision were -4.61-12.00% and <11.12%. The IS normalized recovery was 90.62-98.95% for nicotine and 89.18-101.53% for cotinine, and the IS normalized matrix factor was 106.00-116.44% for nicotine and 100.34-109.85% for cotinine. Both nicotine and cotinine were stable under conventional storage conditions. The validated method has been applied to a pharmacokinetic study in mice to calculate the pharmacokinetic parameters for both analytes.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 生物
小类 | 4 区 生化研究方法 4 区 生化与分子生物学 4 区 分析化学 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 生化研究方法 4 区 生化与分子生物学 4 区 分析化学 4 区 药学
JCR分区:
出版当年[2017]版:
Q3 CHEMISTRY, ANALYTICAL Q3 BIOCHEMICAL RESEARCH METHODS Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Q4 PHARMACOLOGY & PHARMACY
最新[2024]版:
Q3 CHEMISTRY, ANALYTICAL Q3 PHARMACOLOGY & PHARMACY Q4 BIOCHEMICAL RESEARCH METHODS Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Capital Med Univ, Sch Stomatol, Lab Tissue Regenerat & Immunol, 4 Tiantanxili, Beijing 100050, Peoples R China [2]Capital Med Univ, Sch Stomatol, Dept Periodont, Beijing Key Lab Tooth Regenerat & Funct Reconstru, 4 Tiantanxili, Beijing 100050, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Capital Med Univ, Sch Stomatol, Lab Tissue Regenerat & Immunol, 4 Tiantanxili, Beijing 100050, Peoples R China [2]Capital Med Univ, Sch Stomatol, Dept Periodont, Beijing Key Lab Tooth Regenerat & Funct Reconstru, 4 Tiantanxili, Beijing 100050, Peoples R China [3]Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, 119 Nansihuan West Rd, Beijing 100070, Peoples R China [4]Capital Med Univ, Coll Pharmaceut Sci, Dept Clin Pharmacol, Beijing, Peoples R China [*1]Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, 119 Nansihuan West Road, Fengtai District, Beijing 100070, P. R. China. [*2]Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, 4 Tiantanxili, Beijing 100050, P. R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:28514 今日访问量:0 总访问量:1589 更新日期:2025-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)